Literature DB >> 9895207

A quantitative study of neurofibrillary tangles, senile plaques and astrocytes in the hippocampal subdivisions and entorhinal cortex in Alzheimer's disease, normal controls and non-Alzheimer neuropsychiatric diseases.

F Muramori1, K Kobayashi, I Nakamura.   

Abstract

The present quantitative study was performed in order to discriminate pathological substrates for dementia from Alzheimer changes in normal controls (NC) and non-Alzheimer neuropsychiatric diseases (NAND). Regional densities of senile plaques (SP), neurofibrillary tangles (NFT) and astrocytes in the cornu ammonis (CA), subiculum and entorhinal cortex were measured and differences in these densities among Alzheimer's disease (AD), NAND and NC were statistically compared. Densities of NFT in the CA and subiculum were significantly higher in AD than in NAND, and densities of SP in all regions were significantly higher in AD than in NAND. Similarly, NFT density in the subiculum and SP density in all regions were higher in AD than in NC. Regional densities of astrocytes in most regions were closely correlated with those of Alzheimer changes. In conclusion, the attribution of the Alzheimer changes, particularly of NFT, to dementia is neglected when they are confined to the entorhinal cortex. However, the attribution of the Alzheimer changes to dementia should be appreciated when they spread from the entorhinal cortex to the subiculum and/or CA.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9895207     DOI: 10.1111/j.1440-1819.1998.tb02706.x

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  28 in total

1.  Abnormalities of hippocampal surface structure in very mild dementia of the Alzheimer type.

Authors:  Lei Wang; J Philp Miller; Mokhtar H Gado; Daniel W McKeel; Marcus Rothermich; Michael I Miller; John C Morris; John G Csernansky
Journal:  Neuroimage       Date:  2005-10-21       Impact factor: 6.556

2.  Alzheimer disease periventricular white matter lesions exhibit specific proteomic profile alterations.

Authors:  Eduardo M Castaño; Chera L Maarouf; Terence Wu; Maria Celeste Leal; Charisse M Whiteside; Lih-Fen Lue; Tyler A Kokjohn; Marwan N Sabbagh; Thomas G Beach; Alex E Roher
Journal:  Neurochem Int       Date:  2012-12-08       Impact factor: 3.921

3.  Resveratrol Protects Optic Nerve Head Astrocytes from Oxidative Stress-Induced Cell Death by Preventing Caspase-3 Activation, Tau Dephosphorylation at Ser422 and Formation of Misfolded Protein Aggregates.

Authors:  John C Means; Adam A Lopez; Peter Koulen
Journal:  Cell Mol Neurobiol       Date:  2020-01-09       Impact factor: 5.046

4.  Phosphoproteomic analysis reveals site-specific changes in GFAP and NDRG2 phosphorylation in frontotemporal lobar degeneration.

Authors:  Jeremy H Herskowitz; Nicholas T Seyfried; Duc M Duong; Qiangwei Xia; Howard D Rees; Marla Gearing; Junmin Peng; James J Lah; Allan I Levey
Journal:  J Proteome Res       Date:  2010-10-22       Impact factor: 4.466

5.  Chitooligosaccharides attenuate Cu2+-induced cellular oxidative damage and cell apoptosis involving Nrf2 activation.

Authors:  Han-Chang Huang; Liang Hong; Ping Chang; Jiao Zhang; Shu-Yan Lu; Bo-Wen Zheng; Zhao-Feng Jiang
Journal:  Neurotox Res       Date:  2014-12-27       Impact factor: 3.911

Review 6.  Multifunctional molecule ERp57: From cancer to neurodegenerative diseases.

Authors:  Aubryanna Hettinghouse; Ronghan Liu; Chuan-Ju Liu
Journal:  Pharmacol Ther       Date:  2017-07-16       Impact factor: 12.310

7.  Dimebon alters hippocampal amyloid pathology in 3xTg-AD mice.

Authors:  Sylvia E Perez; Muhammad Nadeem; Katherine R Sadleir; Joanna Matras; Christy M Kelley; Scott E Counts; Robert Vassar; Elliott J Mufson
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2012-09-20

8.  Hippocampal shape analysis of Alzheimer disease based on machine learning methods.

Authors:  S Li; F Shi; F Pu; X Li; T Jiang; S Xie; Y Wang
Journal:  AJNR Am J Neuroradiol       Date:  2007-08       Impact factor: 3.825

9.  Plasma biomarkers of astrocytic and neuronal dysfunction in early- and late-onset Alzheimer's disease.

Authors:  Fanny M Elahi; Kaitlin B Casaletto; Renaud La Joie; Samantha M Walters; Danielle Harvey; Amy Wolf; Lauren Edwards; Wilfredo Rivera-Contreras; Anna Karydas; Yann Cobigo; Howard J Rosen; Charles DeCarli; Bruce L Miller; Gil D Rabinovici; Joel H Kramer
Journal:  Alzheimers Dement       Date:  2020-01-16       Impact factor: 21.566

10.  Cerebrospinal Fluid C18 Ceramide Associates with Markers of Alzheimer's Disease and Inflammation at the Pre- and Early Stages of Dementia.

Authors:  Unnur D Teitsdottir; Skarphedinn Halldorsson; Ottar Rolfsson; Sigrun H Lund; Maria K Jonsdottir; Jon Snaedal; Petur H Petersen
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.